+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5321417
  • Report
  • May 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Accuray Incorporated
  • C.R Bard Inc.
  • Elekta AB
  • IBA Group
  • Oncura Inc
  • Roche Diagnostics

Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global oncology devices market.



This report focuses on the oncology devices market which is experiencing strong growth. The report gives a guide to the oncology devices market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the oncology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider oncology devices market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology devices market section of the report gives context. It compares the oncology devices market with other segments of the oncology devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology devices indicators comparison.

Scope

Markets Covered:

1) By Device Type: Brachytherapy Devices; Endoscopic Devices 2) By Therapy: Chemotherapy; Hormone Therapy; Biotherapy/Immunotherapy; Radiation Therapy 3) By End User: Hospitals ; Cancer Research Institutes; Others

Companies Mentioned: Eckert & Ziegler BEBIG; Oncura Inc; GE Healthcare; Medtronic plc; Varian Medical Systems Inc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Frequently Asked Questions about the Global Oncology Devices Market

What is the estimated value of the Global Oncology Devices Market?

The Global Oncology Devices Market was estimated to be valued at $110.4 billion in 2021.

What is the growth rate of the Global Oncology Devices Market?

The growth rate of the Global Oncology Devices Market is 15.6%, with an estimated value of $197.0 billion by 2025.

What is the forecasted size of the Global Oncology Devices Market?

The Global Oncology Devices Market is estimated to be worth $197.0 billion by 2025.

Who are the key companies in the Global Oncology Devices Market?

Key companies in the Global Oncology Devices Market include Eckert & Ziegler BEBIG, Oncura Inc, GE Healthcare, Medtronic plc, Varian Medical Systems Inc, Elekta AB, Theragenics Corporation, Accuray Incorporated and IBA Group.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accuray Incorporated
  • C.R Bard Inc.
  • Elekta AB
  • IBA Group
  • Oncura Inc
  • Roche Diagnostics

1. Executive Summary

2. Oncology Devices Market Characteristics

3. Oncology Devices Market Trends and Strategies

4. Impact of COVID-19 on Oncology Devices

5. Oncology Devices Market Size and Growth
5.1. Global Oncology Devices Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Oncology Devices Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Oncology Devices Market Segmentation
6.1. Global Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Brachytherapy Devices
  • Endoscopic Devices

6.2. Global Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Chemotherapy
  • Hormone Therapy
  • Biotherapy/Immunotherapy
  • Radiation Therapy

6.3. Global Oncology Devices Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Hospitals
  • Cancer Research Institutes
  • Others

7. Oncology Devices Market Regional and Country Analysis
7.1. Global Oncology Devices Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Oncology Devices Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Oncology Devices Market
8.1. Asia-Pacific Oncology Devices Market Overview

  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Oncology Devices Market
9.1. China Oncology Devices Market Overview
9.2. China Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Oncology Devices Market
10.1. India Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Oncology Devices Market
11.1. Japan Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Oncology Devices Market
12.1. Australia Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Oncology Devices Market
13.1. Indonesia Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Oncology Devices Market
14.1. South Korea Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Oncology Devices Market
15.1. Western Europe Oncology Devices Market Overview
15.2. Western Europe Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Oncology Devices Market
16.1. UK Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Oncology Devices Market
17.1. Germany Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Oncology Devices Market
18.4. France Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Oncology Devices Market
19.1. Eastern Europe Oncology Devices Market Overview
19.2. Eastern Europe Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Oncology Devices Market
20.1. Russia Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Oncology Devices Market
21.1. North America Oncology Devices Market Overview
21.2. North America Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Oncology Devices Market
22.1. USA Oncology Devices Market Overview
22.2. USA Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Oncology Devices Market
23.1. South America Oncology Devices Market Overview
23.2. South America Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Oncology Devices Market
24.1. Brazil Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Oncology Devices Market
25.1. Middle East Oncology Devices Market Overview
25.2. Middle East Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Oncology Devices Market
26.1. Africa Oncology Devices Market Overview
26.2. Africa Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Oncology Devices Market Competitive Landscape and Company Profiles
27.1. Oncology Devices Market Competitive Landscape
27.2. Oncology Devices Market Company Profiles
27.2.1. Eckert & Ziegler BEBIG
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Oncura Inc
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. GE Healthcare
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Medtronic plc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Varian Medical Systems Inc
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers and Acquisitions in the Oncology Devices Market

29. Oncology Devices Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accuray Incorporated
  • C.R Bard Inc.
  • Elekta AB
  • IBA Group
  • Oncura Inc
  • Roche Diagnostics
Major players in the oncology devices market are Eckert & Ziegler BEBIG, Oncura Inc, GE Healthcare, Medtronic plc, Varian Medical Systems Inc, Elekta AB, Theragenics Corporation, Accuray Incorporated, and Roche Diagnostics.

The global oncology devices market is expected to grow from $96.335 billion in 2020 to $110.44 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $196.963 billion in 2025 at a CAGR of 16%.

The oncology devices market consists of sales of oncology devices and related services provided by the manufacturer of oncology devices. Oncology is a branch of science that investigates cancer cells. Oncology devices are medical devices used in the diagnosis, management, and treatment of cancer including breast cancer, lung cancer, pancreatic cancer, blood cancer, ovarian cancer, gastric cancer, skin cancer, kidney cancer, and brain tumor.

Major companies in the market, research institutes and governments are continuously focusing on developing new devices to treat cancer patients. For instance, AIROS Medical Inc., a medical technology company based in the USA, launched AIROS 6 sequential compression therapy device and garment system to treat breast cancer patients. The advanced technology expanded upper extremity post-mastectomy treatment options for patients with lymphedema.

The oncology devices market covered in this report is segmented by device type into brachytherapy devices; endoscopic devices. It is also segmented by therapy into chemotherapy; hormone therapy; biotherapy/immunotherapy; radiation therapy and by end user into hospitals; cancer research institutes; others.

In June 2019, Varian Medical Systems, a US-based company that specializes in radiation oncology treatment and software, announced the acquisition of Endocare, Inc., and Alicon for $185 million. With the acquisition of Endocare Inc. and Alicon, Varian Medical Systems plans to expand its cancer care solutions. Endocare, Inc. is a US-based company that offers systems and disposables for cryoablation and microwave ablation. Alicon is a company based in China and engaged in making embolic therapy for treating liver cancer.

A growing number of cancer cases across the globe is anticipated to boost the demand for the oncology devices market. Cancer is a major health problem across the globe and is the second leading cause of death in the USA. The increasing incidence of cancer is contributing to the surge in the demand for oncology devices to treat cancer patients. The four most common types of cancer globally are prostate, lung, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. Therefore, the rise in cancer incidence is anticipated to boost the demand for the oncology drugs market.

The low per capita expenditure on healthcare in developing countries is anticipated to limit the growth of the oncology devices market. The per capital expenditure on healthcare is very low in emerging economies such as China, India, and Indonesia as compared to developed nations. For instance, in 2018, the per capita expenditure in the USA was estimated at $10,586, which was much higher than per capita healthcare expenditure in countries such as India - $209, Indonesia - $301, and China - $688. Low per capita healthcare expenditure is a key restraint for the oncology devices market expansion over the forthcoming years.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Eckert & Ziegler BEBIG
  • Oncura Inc
  • GE Healthcare
  • Medtronic plc
  • Varian Medical Systems Inc
  • Elekta AB
  • Theragenics Corporation
  • Accuray Incorporated
  • Roche Diagnostics
  • IBA Group
  • Biogenex Laboratories
  • C.R Bard Inc.
  • Theragenics Corporation
  • PLC
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll